What Researchers Did
Researchers compared hyperbaric oxygen therapy at two different pressure levels (0.175 MPa and 0.2 MPa) against a control group for 93 patients with aphasia after craniocerebral injury.
What They Found
The total response rate was significantly higher in the HBO treatment groups (83.87% and 87.1%) compared to the control group (58.06%). While both HBO pressures improved aphasia similarly, the 0.175 MPa therapy showed better patient adherence, with a 31.37% lower non-adherence rate than the 0.2 MPa therapy.
What This Means for Canadian Patients
Hyperbaric oxygen therapy could be a beneficial treatment option for Canadian patients experiencing aphasia following a craniocerebral injury. The findings suggest that a lower pressure level (0.175 MPa) might offer similar therapeutic effects with improved patient adherence.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
The study's relatively small sample size and single-center design may limit the generalizability of its findings.